Efficacy and Safety of Two Doses of Liarozole vs. Placebo for the Treatment of Lamellar Ichthyosis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions
Ichthyosis, Lamellar
Interventions
DRUG

Liarozole

Trial Locations (16)

Unknown

Academisch Ziekenhuis Vrije Universiteit Brussel, Brussels

Geel, Geel

Hôpital Saint-Justine, Montreal

Newlab Clinical Research Inc., St. John's

Instituto Dermatologico, Santo Domingo

Hôtel Dieu CHU, Nantes

Tomesa Fachklinik, Bad Salzschlirf

Dueren, Düren

Otto-von-Guericke-Universität, Magdeburg

University Hospital Muenster, Münster

Fondazione Policlinico Mangiagalli e Regina Elena, Milan

Istituto Dermopatico dell'Immacolata, Rome

Academisch Ziekenhuis Maastricht, Maastricht

University Hospital Rotterdam, Rotterdam

Rikshospitalet Universitetsklinikk, Oslo

Uppsala University Hospital, Uppsala

All Listed Sponsors
lead

Stiefel, a GSK Company

INDUSTRY

NCT00282724 - Efficacy and Safety of Two Doses of Liarozole vs. Placebo for the Treatment of Lamellar Ichthyosis | Biotech Hunter | Biotech Hunter